High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
about
Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South AfricaAssociation between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisPredictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence communityOutcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalenceAlcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort studyLoss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South AfricaDevelopment and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South AfricaUnsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa.Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.Characteristics of multidrug-resistant tuberculosis in Namibia.Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmesAchieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia--an observational cohort study.Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study.Factors affecting treatment outcomes in drug-resistant tuberculosis cases in the Northern Cape, South Africa.Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of careRisk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT TrialTuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, MalawiManagement and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam.Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial.Multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa: An overview of patients' reported knowledge and attitudes.A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis.Drug-resistant tuberculosis treatment complicated by antiretroviral resistance in HIV coinfected patients: a report of six cases in Lesotho.Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis (MDR- TB) Compared with Non-MDR-TB Infections in Peninsular MalaysiaPredictors for Mortality among Multidrug-Resistant Tuberculosis Patients in TanzaniaEfficacy and effect of free treatment on multidrug-resistant tuberculosis.Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South AfricaImproved survival and cure rates with concurrent treatment for MDR-TB/HIV co-infection in South Africa.Treatment outcomes of multidrug-resistant tuberculosis in Taiwan: tackling loss to follow-up.Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.Community-based management versus traditional hospitalization in treatment of drug-resistant tuberculosis: a systematic review and meta-analysis.Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis.
P2860
Q21562122-87DAC4F6-3710-4870-A622-F001108E89A4Q27013703-D11CAB89-DA1E-4EA6-B328-DA31F0C17EC8Q28476641-FBE633A4-09A1-4574-A573-3B618E504638Q28479241-DAE6D203-70BC-4F0F-A750-0EC7F88BAB73Q28537696-8906624F-961B-4BFB-9ECB-78EE10A5E622Q28544642-63FC6481-ABE5-465D-812D-92EF5DEA2F0DQ28545021-3DBED826-3242-45E0-AEDB-70DD525FB61CQ33892396-9FAE2D5C-7E74-4FE2-BBD2-00A6EE7CC5ABQ34344980-B6CF411C-AE16-4147-9F51-F3862379C762Q34463467-017A2538-4C36-4CBF-871A-1EE7C048D508Q34526722-AF60FD1A-CD24-4CC0-906F-D198AF2E1891Q35072895-319AD70C-C51B-425D-B8F9-B61B135E30D6Q35144014-01DF7904-C814-4514-9458-AD57C76976A0Q35823335-7A547E01-8DEB-44F1-90BE-D60E875A543CQ35825931-1729C70B-1277-4732-AE26-0CA29FA64543Q35896082-165A4CAD-E1F4-4336-A88F-90249C414595Q35944864-74BA7525-DEC8-49CB-98D0-D98216492282Q36078264-3DB3AD1D-1236-486D-9051-713C0837D039Q36273236-8F1E3DA5-80BB-4090-A1AD-62B973ECFDCFQ36315286-47957A9A-5C3A-41EE-BBFE-08E25DD6BC02Q36627292-371C28DC-9AF0-4651-BD84-730812792C53Q36656601-99CB38A5-729E-4EA0-94C9-2B5FD88F1748Q36734349-4FBB46EC-30C3-48FA-A1A7-B0B1A7CC2C24Q36893640-857E61DD-1B93-49D5-9193-0436635D068BQ36922757-80D68AB3-6409-4BBD-8AE3-3182D7FB206AQ37051367-9B767432-EB3C-4477-93AC-8E9E96906107Q37089599-283C817F-7EF7-4F05-B619-35C669EF8AF2Q37107955-D1D14A9F-A54C-41EC-A150-F6623BE9A098Q37259517-A4A5CD53-7B4E-44ED-B194-1D2D44FE49F3Q38624848-2AB330F6-F56A-4E6F-953D-5815219CDC71Q38718198-A2ECA669-C98D-458B-A4EE-ED3D562BCDCCQ42701720-9F324B12-40CF-41DE-8F50-DE4D384AC4E1Q47558685-B891BBA0-591E-462C-B7D5-FB4A1C95B240Q47638862-11938FD8-AC91-4CE3-BF40-20F1B8DD42B9Q52594133-764842E4-BC83-4256-A1DA-E77895D23231Q53041364-E2F45A0F-8DE0-4E35-B5AC-238305B5332FQ55208580-0BCE369D-1F85-40EB-8D56-E16F49279B62
P2860
High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High treatment failure and def ...... atal, South Africa, 2000-2003.
@ast
High treatment failure and def ...... atal, South Africa, 2000-2003.
@en
High treatment failure and def ...... atal, South Africa, 2000-2003.
@nl
type
label
High treatment failure and def ...... atal, South Africa, 2000-2003.
@ast
High treatment failure and def ...... atal, South Africa, 2000-2003.
@en
High treatment failure and def ...... atal, South Africa, 2000-2003.
@nl
prefLabel
High treatment failure and def ...... atal, South Africa, 2000-2003.
@ast
High treatment failure and def ...... atal, South Africa, 2000-2003.
@en
High treatment failure and def ...... atal, South Africa, 2000-2003.
@nl
P2093
P2860
P921
P1476
High treatment failure and def ...... Natal, South Africa, 2000-2003
@en
P2093
J C M Brust
N Padayatchi
N R Gandhi
P2860
P304
P577
2010-04-01T00:00:00Z